Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
APEX
1 other identifier
interventional
40
1 country
1
Brief Summary
Efficacy of an optimized exposure therapy training is investigated in individuals with heightened social anxiety. Participants will undergo a one-session standardized exposure training, followed by either standard or positive mental rehearsal of the exposure experience. The efficacy is measured by symptom improvement according to subjective ratings one week later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2024
CompletedFirst Submitted
Initial submission to the registry
August 19, 2024
CompletedFirst Posted
Study publicly available on registry
August 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJanuary 9, 2026
January 1, 2026
1.7 years
August 19, 2024
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Social Interaction Anxiety Scale (SIAS)
20-item questionnaire on a 5-point Likert scale (0 = 'not at all'; 4 = 'very strongly') assessing severity of anxiety experienced in social interactions and situations. Total score range: 0 to 80. Higher scores indicate higher severity of social anxiety.
Change from baseline to post-treatment (i.e., 7-9 days)
Liebowitz Social Anxiety Scale (LSAS)
2-items from the Liebowitz Social Anxiety Scale (LSAS) on a 4-point Likert scale (fear: 0 = 'none'; 3 = 'high'; avoidance: 0 = 'never'; 3 = 'usually') assessing fear and avoidance of the in the intervention exposed situations. Higher scores indicating greater level of fear and avoidance.
Change from baseline to post-treatment (i.e., 7-9 days)
Communication Anxiety Inventory (CAI) - Trait Version
21-item questionnaire on a 4-point Likert scale (0 = 'almost never'; 3 = 'almost always') assessing an individual's general level of anxiety in communication situations. Total range score: 0 to 84. Higher scores indicate greater level of communication anxiety.
Change from baseline to post-treatment (i.e., 7-9 days)
Secondary Outcomes (6)
Communication Anxiety Inventory (CAI) - State Version
Baseline
Positive and Negative Affect Schedule (PANAS)
Change from baseline to post-treatment (i.e., 7-9 days)
Post-Event Processing Inventory (PEPI) - Trait Version
Change from baseline to post-treatment (i.e., 7-9 days)
Post-Event Processing Inventory (PEPI) - State Version
Post-treatment
Plymouth Sensory Imagery Questionnaire (PSI-Q)
Baseline
- +1 more secondary outcomes
Study Arms (2)
Exposure + Positive Mental Rehearsal
EXPERIMENTALMental rehearsal of the positive aspects of exposure experience
Exposure + Mental rehearsal
ACTIVE COMPARATORMental rehearsal of the exposure experience
Interventions
After exposure trial, participants are asked about the positive aspects of their exposure experience (e.g., thoughts, feelings), based on which an imagination script is formulated and recounted
After exposure, participants are asked about what happened during the exposure experience and whether their central concerns/expected outcome actually occurred during exposure
All participants complete exposure exercises (i.e., talking on the phone and talking with a stranger) before positive mental rehearsal is executed
Eligibility Criteria
You may qualify if:
- Elevated score on Social Interactions Anxiety Scale (SIAS) \> 26
You may not qualify if:
- Current psychotherapeutic/psychiatric treatment
- Plans to start psychotherapeutic/psychiatric treatment in upcoming weeks
- Current suicidal intent
- Severe cardiovascular, respiratory or neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Germany Philipps University
Marburg, 35037, Germany
Related Publications (4)
Rosenberg BM, Barnes-Horowitz NM, Zbozinek TD, Craske MG. Reward processes in extinction learning and applications to exposure therapy. J Anxiety Disord. 2024 Aug;106:102911. doi: 10.1016/j.janxdis.2024.102911. Epub 2024 Jul 29.
PMID: 39128178BACKGROUNDMcGlade AL, Craske MG. Optimizing exposure: Between-session mental rehearsal as an augmentation strategy. Behav Res Ther. 2021 Apr;139:103827. doi: 10.1016/j.brat.2021.103827. Epub 2021 Feb 11.
PMID: 33607459BACKGROUNDCraske MG, Meuret AE, Echiverri-Cohen A, Rosenfield D, Ritz T. Positive affect treatment targets reward sensitivity: A randomized controlled trial. J Consult Clin Psychol. 2023 Jun;91(6):350-366. doi: 10.1037/ccp0000805. Epub 2023 Mar 9.
PMID: 36892884BACKGROUNDCraske MG, Meuret AE, Ritz T, Treanor M, Dour H, Rosenfield D. Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. J Consult Clin Psychol. 2019 May;87(5):457-471. doi: 10.1037/ccp0000396.
PMID: 30998048BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 19, 2024
First Posted
August 21, 2024
Study Start
May 28, 2024
Primary Completion
February 1, 2026
Study Completion
March 1, 2026
Last Updated
January 9, 2026
Record last verified: 2026-01